Evercore

8 results

Once a drug is ready to sell, governments are likely to compete to put their citizens first. Photograph: EPA

It was Friday March 13th when doctors at the largest healthcare provider in New York City decided to take the search for a coronavirus drug into their(...)

The enlarged group now employs more than 1,500 staff in 64 markets.

The majority stakeholder in Galway-based financial payments group Planet, formerly Fintrax, is reportedly planning to sell the group for $2.2 billion (...)

Kerry Group, the global taste and nutrition and consumer foods group led by  Edmond Scanlon (above) has lost out on a major deal in the nutrition sector

Kerry Group has lost out in its bid to buy the nutrition business of US chemicals group DuPont, sending shares in the company down 3 per cent. Rival (...)

AIB sold a portfolio of loans that had an original value of almost €3 billion to a group led by US distressed debt giant Cerberus in April. Photograph: Crispin Rodwell/Bloomberg

Banks in the Republic have been the second-most-active sellers of problem loans so far this year, behind Italy, according to US investment bank Everco(...)

 The Huntstown gas power station, a unit of Viridian Group, in Huntstown near Dublin.  Photograph: Aidan Crawley/Bloomberg via Getty Images

The value of bonds in Viridian edged higher on Friday as it emerged that the Northern Ireland power company’s US owner, I-Squared Capital, is consider(...)

Saudi Arabia’s crown prince announced the plan to sell about 5 per cent of Aramco in 2016, predicting the sale would value the whole company at $2 trillion (€1.72 trillion) or more.

Saudi Arabia has called off both the domestic and international stock listing of state oil giant Aramco, billed as the biggest such deal in history, f(...)

Nama chairman Frank Daly. “Investors will keep an eye on Ireland, with the possibility of further sales from Nama,” the report said. Photograph: Eric Luke

Ireland retained its position as the top European location for distressed loan sales for the fourth year in a row in 2016, driven by Nama’s ongoing wi(...)

GlaxoSmithKline said last week it had received “very significant” indicative bids from private equity companies. Photographer: Chris Ratcliffe/Bloomberg

Private equity groups are exploring a $10 billion (€7.4 billion) plan to buy hundreds of older drug brands from GlaxoSmithKline (GSK) and Sanofi and m(...)